DUBLIN, Ohio (AP) _ Navidea Biopharmaceuticals Inc. (NAVB) on Thursday reported a loss of $2.7 million in its first quarter.
On a per-share basis, the Dublin, Ohio-based company said it had a loss of 13 cents.
The biopharmaceutical posted revenue of $156,300 in the period. Its adjusted revenue was $156,000.
In the final minutes of trading on Thursday, the company's shares hit 96 cents. A year ago, they were trading at $1.65.